Dimerization properties of mutant thyroid hormone β-receptors with auxiliary proteins

Journal of Endocrinology

Volumn 154, Issue 3, 1997, Pages 523-533

  Tagami, T ^a,c   Nakamura, H ^b   Sasaki, S ^a   Miyoshi, Y ^a   Nakao, K ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID X RECEPTOR; THYROID HORMONE;

ARTICLE; DIMERIZATION; GENE MUTATION; HORMONE RECEPTOR INTERACTION; HORMONE RESISTANCE; HORMONE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SPECIFICITY;

BASE SEQUENCE; CELL LINE; CELL NUCLEUS; DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LIVER; MOLECULAR SEQUENCE DATA; MUTATION; PROTEINS; RECEPTORS, RETINOIC ACID; RECEPTORS, THYROID HORMONE; RETINOID X RECEPTORS; THYROID HORMONE RESISTANCE SYNDROME; TRANSCRIPTION FACTORS;

EID: 0030833191     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1540523     Document Type: Article

References (48)

1. Adams M, Matthews C, Collingwgod TN, Tone Y, Beck-Peccoz P & Chatterjee KK 1994 Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene. Journal of Clinical Investigations 94 506-515.
2. Anderson ML, Nordstrom K, Demczuk S, Harbers M & Vennstrom B 1992 Thyroid hormone alters the DNA binding properties of chicken thyroid hormone receptors α and β. Nucleic Acids Research 20 4803-4810.
3. Ando S, Nakamura H, Sasaki S, Nishiyama K, Kitshara A, Nagasawa S, Mikarmi T, Natsume H, Genma R. & Yoshimi T 1996 Introducing a point mutation identified in a patient with pituitary resistance to thyroid hormone (Arg 338 to Trp) into other mutant thyroid hormone receptors weakens their dominant negative activities. Journal of Endocrinology 151 293-300.
4. Au-Fliegner M, Helmer E, Casanova J, Raaka BM & Samuels HH 1993 The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverge responses by affecting heterodimer but not homodimer formation. Molecular and Cellular Biology 13 5725-5737.
5. Berrodin TJ, Marks MS, Ozato K, Linney E & Lazar MA 1992 Heterodimerization among thyroid hormone receptor, retinoic acid receptor, retinoid X receptor, chicken ovalbumin upstream promoter transcription factor, and an endogenous liver protein. Molecular Endocrinology 6 1468-1478.
6. Brent GA, Williams GR, Harney JW, Forman BM, Samuels HH, Moore DD & Larsen PR 1992 Capacity for cooperative binding of thyroid hormone (T3) receptor dimers defines wild type T3 response elements. Molecular Endocrinology 6 502-514.
7. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ & Parker MG 1995 Nuclear factor R1P140 modulates transcriptional activation by the estrogen receptor. EMBO Journal 14 3741-3751.
8. Chen JD & Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377 454-457.
9. Collingwood TN, Adams M, Tone Y & Chatterjee VK 1994 Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome. Molecular Endocrinology 8 1262-1277.
10. DeGroot LJ 1993 Editorial: TRAPS: thyroid receptor auxiliary proteins. Endocrinology 133 963-964.
11. Dignam JD, Lebovitz RM & Roeder RG 1983 Accurate transcription inhibition by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Research 11 1475-1489.
12. Flynn TR, Hollenberg AN, Cohen O, Menke JB, Usala SJ, Tollin S, Hegarty MK & Wondisford FE 1994 A novel C-terminal domain in the thyroid hormone receptor selectively mediates thyroid hormone inhibition. Journal of Biological Chemistry 269 32713-32716.
13. Forman BM & Samuels HH 1990 Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model. Molecular Endocrinology 4 1293-1301.
14. Geffner ME, Su F, Ross NS, Hershman JM, Van Dop C, Menke JB, Hao E, Stanzak RK, Eaton T, Samuels HH & Usala SJ 1993 An arginine to histidine mutation in codon 311 of the C-erbA beta gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype. Journal of Clinical Investigations 91 538-546.
15. Gershengom MC & Weintraub BD 1975 Thyrotropin-induced hyperthyioidism caused by selective pituitary resistance to thyroid hormone: a new syndrome of 'inappropriate secretion of TSH'. Journal of Clinical Investigations 56 633-642.
16. Groenhout EG & Dorin RI 1994 Generalized thyroid hormone resistance due to a deletion of the carboxy terminus of the c-erbA beta receptor. Molecular Cellular Endocrinology 99 81-88.
17. Hao E, Menke JB, Smith AM, Jones C, Geffner ME, Hershman JM, Wuerth JP, Samuels HH, Ways DK & Usala SJ 1994 Divergent dimerization properties of mutant beta 1 thyroid hormone receptors are associated with different dominant negative activities. Molecular Endocrinology 8 841-851.
18. 3)-binding domain of the thyroid honnone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone. Journal of Clinical Investigations 94 607-615.
19. Hayashi Y, Weiss RE, Same DH, Yen PM, Sunthornthepvarakul T, Marcocci C, Chin WW & Refetoff S 1995 Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors? Journal of Clinical Endocrinology and Metabolism 80 3246-3256.
20. Higuchi R 1989 Simple and rapid preparation of samples for PCR. In PCR Technology, pp 31-38. Ed HA Erlich. New York: Stockton Press.
21. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK & Rosenfeld MG 1995 Ligand-independent repression by the thyroid honnone receptor mediated by a nuclear receptor co-repressor. Nature 377 397-404.
22. Hosokawa K, Murayama H, Kasuga A, Ikemoto K, Kataoka K & Saruta T 1988 A case with the syndrome of resistance to thyroid hormone. Folia Endocrinology Japan 64 858 (Abstract).
23. Kitajima K, Nagaya T & Jameson JL 1995 Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization. Thyroid 5 343-353.
24. Kusano S, Kawai H, Yamashita I, Asaishi T, Ishji T & Matuo N 1992 A case of generalized thyroid honnone resistance accompanied by low TBG. Hormone to Rinsho 40 102-104.
25. Le Douarin B, Zechel C, Garnier J-M, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P & Losson R 1995 The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO Journal 14 2020-2033.
26. Lee JW, Choi HS, Gyuris J, Brent R & Moore DD 1995 Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Molecular Endocrinology 9 243-254.
27. Meier CA, Parkison C, Chen A, Ashizawa K, Meier-Heusler SC, Muchmore P, Cheng SY & Weintraub BD 1993 Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T, response element-dependent dominant negative potency. Journal of Clinical Investigations 92 1986-1993.
28. Mixon AJ, Renault JC, Ransom S, Bodenner DL & Weintraub BD 1993 Identification of a novel mutation in the gene encoding the β-triiodothyronine receptor in a patient with apparent selective pituitary resistance to thyroid hormone. Clinical Endocrinolgy 38 227-234.
29. 3 receptor β gene resulting in an 11-amino acid truncation in a patient with generalized resistance to thyroid hormone. Molecular and Cellular Endocrinology 114 9-17.
30. Nagaya T & Jameson JL 1993 Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. Journal of Biological Chemistry 268 15766-15771.
31. Onate SA, Tsai SY, Tsai MJ & O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270 1354-1357.
32. Parrilla R, Mixon AJ, McPhenon JA, McClakey JH & Weintraub BD 1991 Characterization of seven novel mutations of the c-erbAβ gene in unrelated kindreds with generalized thyroid hormone resistance: evidence for two 'hot spot' regions of the ligand binding domain. Journal of Clinical Investigations 88 2123-2130.
33. Piedrafita FJ, Ortiz MA & Pfahl M 1995 Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function. Molecular Endocrinology 9 1533-1548.
34. Refetoff S, Weiss RE & Usala SJ 1993 The syndromes of resistance to thyroid hormone. Endocrine Reviews 14 348-399.
35. Ribeiro RCJ, Apriletti JW, Yen PM, Chin WW & Baxter JD 1994 Heterodimerization and deoxyribonucleic acid-binding properties of a retinoid X receptor-related factor. Endocrinology 135 2076-2085.
36. Rosen ED, Beninghof EG & Koenig RJ 1993 Ligand-dependent synergy of thyroid hormone and retinoid X receptors. Journal of Biological Chemistry 268 11534-11541.
37. 3 receptor β1 gene in a kindred of generalized resistance to thyroid hormone. Molecular and Cellular Endocrinology 84 159-166.
38. Sasaki S, Nakamura H, Tagami T, Miyoshi Y, Nogimori T, Mitsuma T & Imura H 1993 Pituitary resistance to thyroid hormone associated with a base mutation in the hormone-binding domain of the human 3,5,3′-triiodothyronine receptor-β. Journal of Clinical Endocrinology and Metabolism 76 1254-1258.
39. 3 receptor β (R338W) identified in a subject with pituitary resistance to thyroid hormone. Molecular and Cellular Endocrinology 113 109-117.
40. Spanjaad RA, Darling DS & Chin WW 1991 Ligand-binding and heterodimerization activities of a conserved region in the ligand-binding domain of the thyroid hormone receptor. Proceedings of the National Academy of Sciences of the USA 88 8587-8591.
41. Sugawara A, Yen PM, Darling DS & Chin WW 1993 Characterization and tissue expression of multiple triiodothyronine receptor-auxiliary proteins and their relationship to the retinoid X-receptors. Endocrinology 133 965-971.
42. 3 receptors and antiserum against cellular-erbA peptide. Endocrinology 126 1105-1111.
43. Takeda K, Weiss RE & Refetoff S 1992 Rapid localization of mutations in the thyroid hormone receptor β gene by denaturing gel electrophoresis in eighteen families with thyroid hormone resistance. Journal of Clinical Endocrinology and Metabolism 74 712-719.
44. Umesono K, Murakami KK, Thompson CC & Evans RM 1991 Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D receptors. Cell 65 1255-1266.
45. Usala SJ, Tennyson GE, Bale AE, Lash RW, Gesundheit N, Wondisford FE, Accili D, Hauser P & Weintraub BD 1990 A base mutation of the c-erbAβ thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Journal of Clinical Investigations 85 93-100.
46. Weiss RE, Weinberg M & Refetoff S 1993 Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor βgene. Journal of Clinical Investigations 91 2408-2415.
47. Weiss RE, Stein MA, Duck SC, Chyna B, Phillips W, O'Bnen T, Gutermuth L & Refetoff S 1994 Low intelligence but not attention deficit hyperactivity disorder is associated with resistance to thyroid hormone caused by mutation R316H in the thyroid hormone receptor-β gene. Journal of Clinical Endocrinology and Metabolism 78 1525-1528.
48. 3-receptor homodimers but not receptor-auxiliary protein heterodimers. Journal of Biological Chemistry 267 3565-3568.